Exkivity: Treating Rare Lung Cancer
Aluko Studio
Art Director
Packaging Designer
Visual Designer
Adobe Dimension
Adobe Illustrator
Adobe XD
BGB Group
Takeda
Exkivity is an oral lung cancer medication developed by Takeda Pharmaceutical to treat Non-small cell lung cancer (NSCLC).
Mission
BGB Group worked on strategy, and some initial concepts while waiting for the drugs approval. I worked with them to develop launch collateral.
Outcome
I aided in the development of the look & feel including banner ads, icons, email templates and packaging.
BRANDED CVA ICONS
NOW APPROVED EMAIL
WELCOME KIT
BRANDED PLAYBOOK
